Literature DB >> 10567553

Identification of a portable repression domain and an E1A-responsive activation domain in Pax4: a possible role of Pax4 as a transcriptional repressor in the pancreas.

Y Fujitani1, Y Kajimoto, T Yasuda, T A Matsuoka, H Kaneto, Y Umayahara, N Fujita, H Watada, J I Miyazaki, Y Yamasaki, M Hori.   

Abstract

Pax4 is a paired-domain (PD)-containing transcription factor which plays a crucial role in pancreatic beta/delta-cell development. In this study, we characterized the DNA-binding and transactivation properties of mouse Pax4. Repetitive rounds of PCR-based selection led to identification of the optimal DNA-binding sequences for the PD of Pax4. In agreement with the conservation of the optimal binding sequences among the Pax family transcription factors, Pax4 could bind to the potential binding sites for Pax6, another member of the Pax family also involved in endocrine pancreas development. The overexpression of Pax4 in HIT-T15 cells dose dependently inhibited the basal transcriptional activity as well as Pax6-induced activity. Detailed domain mapping analyses using GAL4-Pax4 chimeras revealed that the C-terminal region of Pax4 contains both activation and repression domains. The activation domain was active in the embryonic kidney-derived 293/293T cells and embryonal carcinoma-derived F9 cells, containing adenoviral E1A protein or E1A-like activity, respectively but was inactive or very weakly active in other cells including those of pancreatic beta- and alpha-cell origin. Indeed, the exogenous overexpression of type 13S E1A in heterologous cell types could convert the activation domain to an active one. On the other hand, the repression domain was active regardless of the cell type. When the repression domain was linked to the transactivation domain of a heterologous transcription factor, PDX-1, it could completely abolish the transactivation potential of PDX-1. These observations suggest a primary role of Pax4 as a transcriptional repressor whose function may involve the competitive inhibition of Pax6 function. The identification of the E1A-responsive transactivation domain, however, indicates that the function of Pax4 is subject to posttranslational regulation, providing further support for the complexity of mechanisms that regulate pancreas development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567553      PMCID: PMC84912          DOI: 10.1128/MCB.19.12.8281

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

1.  Cellular targets for transformation by the adenovirus E1A proteins.

Authors:  P Whyte; N M Williamson; E Harlow
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

2.  Transcription activation by the adenovirus E1a protein.

Authors:  J W Lillie; M R Green
Journal:  Nature       Date:  1989-03-02       Impact factor: 49.962

Review 3.  Transcriptional and transforming activities of the adenovirus E1A proteins.

Authors:  T Shenk; J Flint
Journal:  Adv Cancer Res       Date:  1991       Impact factor: 6.242

4.  The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein.

Authors:  T Chittenden; D M Livingston; W G Kaelin
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

5.  A vector for expressing GAL4(1-147) fusions in mammalian cells.

Authors:  I Sadowski; M Ptashne
Journal:  Nucleic Acids Res       Date:  1989-09-25       Impact factor: 16.971

6.  Pax: a murine multigene family of paired box-containing genes.

Authors:  C Walther; J L Guenet; D Simon; U Deutsch; B Jostes; M D Goulding; D Plachov; R Balling; P Gruss
Journal:  Genomics       Date:  1991-10       Impact factor: 5.736

7.  Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains.

Authors:  F Liu; M R Green
Journal:  Nature       Date:  1994-04-07       Impact factor: 49.962

8.  Identification of a Pax paired domain recognition sequence and evidence for DNA-dependent conformational changes.

Authors:  J Epstein; J Cai; T Glaser; L Jepeal; R Maas
Journal:  J Biol Chem       Date:  1994-03-18       Impact factor: 5.157

9.  Common control of the heat shock gene and early adenovirus genes: evidence for a cellular E1A-like activity.

Authors:  M J Imperiale; H T Kao; L T Feldman; J R Nevins; S Strickland
Journal:  Mol Cell Biol       Date:  1984-05       Impact factor: 4.272

10.  Transactivation of the adenovirus EIIa promoter in the absence of adenovirus E1A protein is restricted to mouse oocytes and preimplantation embryos.

Authors:  T P Dooley; M Miranda; N C Jones; M L DePamphilis
Journal:  Development       Date:  1989-12       Impact factor: 6.868

View more
  18 in total

1.  Developmental and diurnal dynamics of Pax4 expression in the mammalian pineal gland: nocturnal down-regulation is mediated by adrenergic-cyclic adenosine 3',5'-monophosphate signaling.

Authors:  Martin F Rath; Michael J Bailey; Jong-So Kim; Anthony K Ho; Pascaline Gaildrat; Steven L Coon; Morten Møller; David C Klein
Journal:  Endocrinology       Date:  2008-09-25       Impact factor: 4.736

2.  The evolution of alternative splicing in the Pax family: the view from the Basal chordate amphioxus.

Authors:  Stephen Short; Linda Z Holland
Journal:  J Mol Evol       Date:  2008-05-14       Impact factor: 2.395

3.  PAX4 Gene Transfer Induces α-to-β Cell Phenotypic Conversion and Confers Therapeutic Benefits for Diabetes Treatment.

Authors:  Yanqing Zhang; Genevieve E Fava; Hongjun Wang; Franck Mauvais-Jarvis; Vivian A Fonseca; Hongju Wu
Journal:  Mol Ther       Date:  2015-10-05       Impact factor: 11.454

Review 4.  Are Pax proteins potential therapeutic targets in kidney disease and cancer?

Authors:  Edward Grimley; Gregory R Dressler
Journal:  Kidney Int       Date:  2018-04-21       Impact factor: 10.612

5.  An Arabidopsis basic helix-loop-helix leucine zipper protein modulates metal homeostasis and auxin conjugate responsiveness.

Authors:  Rebekah A Rampey; Andrew W Woodward; Brianne N Hobbs; Megan P Tierney; Brett Lahner; David E Salt; Bonnie Bartel
Journal:  Genetics       Date:  2006-10-08       Impact factor: 4.562

6.  Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity.

Authors:  A Biason-Lauber; B Boehm; M Lang-Muritano; B R Gauthier; T Brun; C B Wollheim; E J Schoenle
Journal:  Diabetologia       Date:  2005-04-15       Impact factor: 10.122

7.  NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes.

Authors:  Zhi-Cheng Gong; Qiong Huang; Xing-Ping Dai; Guang-Hua Lei; Hong-Bin Lu; Ji-Ye Yin; Xiao-Jing Xu; Jian Qu; Qi Pei; Min Dong; Bo-Ting Zhou; Jie Shen; Gan Zhou; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

8.  A common functional regulatory variant at a type 2 diabetes locus upregulates ARAP1 expression in the pancreatic beta cell.

Authors:  Jennifer R Kulzer; Michael L Stitzel; Mario A Morken; Jeroen R Huyghe; Christian Fuchsberger; Johanna Kuusisto; Markku Laakso; Michael Boehnke; Francis S Collins; Karen L Mohlke
Journal:  Am J Hum Genet       Date:  2014-01-16       Impact factor: 11.025

9.  Transcriptional activities of the Pax6 gene eyeless regulate tissue specificity of ectopic eye formation in Drosophila.

Authors:  Bonnie M Weasner; Brandon Weasner; Stephanie M Deyoung; Scott D Michaels; Justin P Kumar
Journal:  Dev Biol       Date:  2009-05-04       Impact factor: 3.582

10.  Pleiotropic Roles of PDX-1 in the Pancreas.

Authors:  Hideaki Kaneto; Takeshi Miyatsuka; Dan Kawamori; Taka-Aki Matsuoka
Journal:  Rev Diabet Stud       Date:  2008-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.